NASDAQ
CLOV
Last Price
US $4.82
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
Clover Health Investments, Corp. carries no debt; cash flow comfortably covers obligations.
Financial risk - Healthy cash flow growth.
Clover Health Investments, Corp.'s free cash flow has decreased -307.21% from $33.29M last year to $-68.98M, signaling decreasing performance
Financial stability - Healthy debt to equity ratio.
Clover Health Investments, Corp.'s debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial risk - Healthy debt to equity ratio development.
Clover Health Investments, Corp. has insufficient data to evaluate this check.
Financial risk - Net debt/EBITDA.
Clover Health Investments, Corp. has negative EBITDA, making leverage ratio unreliable
Financial stability - ICR.
Clover Health Investments, Corp. carries no debt; interest obligations are fully covered.
Financial stability - Profit margin growth.
Clover Health Investments, Corp.'s profit margin has increased (-17.90%) in the last year from -3.14% to -2.58%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Clover Health Investments, Corp.'s short-term assets of $307.86M exceed its short-term liabilities of $208.82M
Decreasing performance - ROA.
Clover Health Investments, Corp.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Clover Health Investments, Corp.'s return on equity of -17.08%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
Clover Health Investments, Corp.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
Clover Health Investments, Corp. had positive net income in only 0.00 out of 5 years, indicating unstable earnings
Decreasing performance - Free cash flow.
Clover Health Investments, Corp. has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
Clover Health Investments, Corp. has negative free cash flow, indicating cash burn
Decreasing performance - Healthy earnings growth.
Clover Health Investments, Corp.'s yearly earnings has decreased 98.91% since last year from $-43.01M to $-85.55M, signaling decreasing performance
Increasing performance - Healthy revenue growth.
Clover Health Investments, Corp.'s yearly revenue has increased 40.34% since last year from $1.37G to $1.92G, signaling increasing performance
Decreasing performance - ROIC.
ROIC -15.76% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Increasing performance - 3-year revenue CAGR.
Clover Health Investments, Corp.'s 3-year revenue CAGR of 20.62% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Clover Health Investments, Corp. had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Decreasing performance - ROE consistency.
Clover Health Investments, Corp. had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
Clover Health Investments, Corp. has insufficient data to evaluate this check.
Overvalued - Earnings yield.
Clover Health Investments, Corp. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
Clover Health Investments, Corp. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Clover Health Investments, Corp. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
Clover Health Investments, Corp. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - P/B ratio.
Clover Health Investments, Corp. has a price-to-book ratio of 7.42x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value
Undervalued - P/S ratio.
Clover Health Investments, Corp. has a price-to-sales ratio of 1.14x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-17.08%
Return on equity
ROIC: -15.76%
Valuation History
-39.9X
Price to Earnings
EV/EBITDA: -38.5X
Cash flow
Profit margin
-1.26%
(FY vs FY)
Cash flow Y/Y
11.56%
(FY vs FY)
Fair Value
Market $4.82
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.